Burning mouth disorder and Parkinson's disease: A scoping review of the literature.
Parkinson's disease
burning mouth disorder
burning mouth syndrome
movement disorders
neurodegenerative diseases
stomatodynia
Journal
Journal of oral rehabilitation
ISSN: 1365-2842
Titre abrégé: J Oral Rehabil
Pays: England
ID NLM: 0433604
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
revised:
13
02
2023
received:
25
07
2022
accepted:
20
02
2023
medline:
4
5
2023
pubmed:
2
3
2023
entrez:
1
3
2023
Statut:
ppublish
Résumé
Burning mouth disorder (BMD) is a complex medical condition characterized by a burning sensation in the mouth of fluctuating intensity. BMD is considered a diagnosis of exclusion, as oral burning can occur secondary to local or systemic conditions. Parkinson's disease (PD) is one such condition. To provide a scoping review of the literature by assessing all articles written in English that investigated the relationship between BMD and PD. Various databases (PubMed, Ovid, Web of Science, Science Direct and Scopus) and a search platform (EBSCOhost) were searched following similar investigative approaches. Duplicates were removed and reference lists of original studies were scrutinized for additional articles. Any decision about the inclusion/exclusion in the review was by consensus among the co-authors. Twenty-five original articles and one supplemental article were included in the final review, of which 13 met the inclusion criteria. These were further divided into five categories based on the study design/article, which included Prevalence studies (n = 6), Letter to the editor (n = 1), Incidence study (n = 1), Case reports (n = 2) and Experimental studies (n = 3). Strongest data was provided by epidemiological studies, which suggest BMD and PD are poorly associated. A scoping review of the existing literature does not suggest that PD patients are any more at risk of developing BMD compared to the general population. While there may be a link through the dopaminergic system as determined by imaging studies, it is unlikely that the pathogenesis of PD disease shares significant commonality with BMD.
Sections du résumé
BACKGROUND
BACKGROUND
Burning mouth disorder (BMD) is a complex medical condition characterized by a burning sensation in the mouth of fluctuating intensity. BMD is considered a diagnosis of exclusion, as oral burning can occur secondary to local or systemic conditions. Parkinson's disease (PD) is one such condition.
OBJECTIVE
OBJECTIVE
To provide a scoping review of the literature by assessing all articles written in English that investigated the relationship between BMD and PD.
MATERIALS AND METHODS
METHODS
Various databases (PubMed, Ovid, Web of Science, Science Direct and Scopus) and a search platform (EBSCOhost) were searched following similar investigative approaches. Duplicates were removed and reference lists of original studies were scrutinized for additional articles. Any decision about the inclusion/exclusion in the review was by consensus among the co-authors.
RESULTS
RESULTS
Twenty-five original articles and one supplemental article were included in the final review, of which 13 met the inclusion criteria. These were further divided into five categories based on the study design/article, which included Prevalence studies (n = 6), Letter to the editor (n = 1), Incidence study (n = 1), Case reports (n = 2) and Experimental studies (n = 3). Strongest data was provided by epidemiological studies, which suggest BMD and PD are poorly associated.
CONCLUSIONS
CONCLUSIONS
A scoping review of the existing literature does not suggest that PD patients are any more at risk of developing BMD compared to the general population. While there may be a link through the dopaminergic system as determined by imaging studies, it is unlikely that the pathogenesis of PD disease shares significant commonality with BMD.
Substances chimiques
Dopamine
VTD58H1Z2X
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
488-500Informations de copyright
© 2023 The Authors. Journal of Oral Rehabilitation published by John Wiley & Sons Ltd.
Références
International classification of orofacial pain, 1st edition (ICOP). Cephalalgia. 2020;40:129-221.
Miller CS, Farag AM, Chmieliauskaite M, et al. Is burning mouth a syndrome or a disorder? A commentary. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127:361-363.
Kim MJ, Kim J, Kho HS. Comparison of clinical characteristics between burning mouth syndrome patients with bilateral and unilateral symptoms. Int J Oral Maxillofac Surg. 2020;49:38-43.
Sun A, Wu KM, Wang YP, Lin HP, Chen HM, Chiang CP. Burning mouth syndrome: a review and update. J Oral Pathol Med. 2013;42:649-655.
Abetz LM, Savage NW. Burning mouth syndrome and psychological disorders. Aust Dent J. 2009;54:84-93. quiz 173.
Dahiya P, Kamal R, Kumar M, Niti GR, Gupta R, Chaudhary K. Burning mouth syndrome and menopause. Int J Prev Med. 2013;4:15-20.
Puhakka A, Forssell H, Soinila S, et al. Peripheral nervous system involvement in primary burning mouth syndrome-results of a pilot study. Oral Dis. 2016;22:338-344.
Clifford TJ, Warsi MJ, Burnett CA, Lamey PJ. Burning mouth in Parkinson's disease sufferers. Gerodontology. 1998;15:73-78.
Berg D, Postuma RB, Bloem B, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord. 2014;29:454-462.
Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988;51:745-752.
Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56:33-39.
Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30:1591-1601.
Jääskeläinen SK, Forssell H, Tenovuo O. Abnormalities of the blink reflex in burning mouth syndrome. Pain. 1997;73:455-460.
Jääskeläinen SK, Rinne JO, Forssell H, et al. Role of the dopaminergic system in chronic pain - a fluorodopa-PET study. Pain. 2001;90:257-260.
Kolkka M, Forssell H, Virtanen A, Puhakka A, Pesonen U, Jääskeläinen SK. Neurophysiology and genetics of burning mouth syndrome. Eur J Pain. 2019;23:1153-1161.
Hagelberg N, Forssell H, Rinne JO, et al. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain. 2003;101(1-2):149-154.
Forssell H, Jääskeläinen S, Tenovuo O, Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain. 2002;99(1-2):41-47.
Stuginski-Barbosa J, Rodrigues GG, Bigal ME, Speciali JG. Burning mouth syndrome responsive to pramipexol. J Headache Pain. 2008;9:43-45.
Cárcamo Fonfría A, Gómez-Vicente L, Pedraza MI, Cuadrado-Pérez ML, Guerrero Peral AL, Porta-Etessam J. Burning mouth syndrome: clinical description, pathophysiological approach, and a new therapeutic option. Neurologia. 2017;32:219-223.
Ueda N, Kodama Y, Hori H, et al. Two cases of burning mouth syndrome treated with olanzapine. Psychiatry Clin Neurosci. 2008;62:359-361.
Rodriguez-Cerdeira C, Sanchez-Blanco E. Treatment of burning mouth syndrome with amisulpride. J Clin Med Res. 2012;4:167-171.
Maina G, Vitalucci A, Gandolfo S, Bogetto F. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry. 2002;63:38-43.
Bogetto F, Bonatto Revello R, Ferro G, Maina G, Ravizza L. Psychopharmacological treatment of Burning Mouth Syndrome (BMS). A study on a sample of 121 patients. Minerva Psichiatr. 1999;40:1.
Demarosi F, Tarozzi M, Lodi G, Canegallo L, Rimondini L, Sardella A. The effect of levosulpiride in burning mouth syndrome. Minerva Stomatol. 2007;56:21-26.
Galli F, Pravettoni G. Burning mouth syndrome-opening the door to a psychosomatic approach in the era of patient-centered medicine. JAMA Otolaryngol Head Neck Surg. 2020;146:569-570.
Kim JY, Kim YS, Ko I, Kim DK. Association between burning mouth syndrome and the development of depression, anxiety, dementia, and Parkinson disease. JAMA Otolaryngol Head Neck Surg. 2020;146:561-569.
Bonenfant D, Rompré PH, Rei N, et al. Characterization of burning mouth syndrome in patients with Parkinson's disease. J Oral Facial Pain Headache. 2016;30:318-322.
Koszewicz M, Mendak M, Konopka T, Koziorowska-Gawron E, Budrewicz S. The characteristics of autonomic nervous system disorders in burning mouth syndrome and Parkinson disease. J Orofac Pain. 2012;26:315-320.
Coon EA, Laughlin RS. ‘Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause?’ Letter to the editor reply. J Headache Pain. 2012;13:687.
Coon EA, Laughlin RS. Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause? J Headache Pain. 2012;13:255-257.
Fortuna G, Pollio A. Drug-induced burning mouth syndrome: a new clinico-pathological entity? J Headache Pain. 2012;13:685-686.
Dirks SJ, Paunovich ED, Terezhalmy GT, Chiodo LK. The patient with Parkinson's disease. Quintessence Int. 2003;34:379-393.
Langer A. Prosthodontic failures in patients with systemic disorders. J Oral Rehabil. 1979;6:13-19.
Prete BRJ, Ouanounou A. Medical management, orofacial findings, and dental care for the patient with Parkinson's disease. J Can Dent Assoc. 2021;87:l10.
Martinez-Martin P, Manuel Rojo-Abuin J, Rizos A, et al. Distribution and impact on quality of life of the pain modalities assessed by the King's Parkinson's disease pain scale. NPJ Parkinsons Dis. 2017;3:8.
Verhoeff MC, Lobbezoo F, van Leeuwen AM, Schuller AA, Koutris M. Oral health-related quality of life in patients with Parkinson's disease. J Oral Rehabil. 2022;49:398-406.
Wood PB. Role of central dopamine in pain and analgesia. Expert Rev Neurother. 2008;8:781-797.
Smolensky MH, Portaluppi F, Manfredini R, et al. Diurnal and twenty-four hour patterning of human diseases: acute and chronic common and uncommon medical conditions. Sleep Med Rev. 2015;21:12-22.
O'Neill F, Kobylecki C, Carrasco R, Hu MT, Grosset D, Silverdale M. Orofacial pain in 1916 patients with early or moderate Parkinson disease. Pain Rep. 2021;6:e923.
Ukai K. Tactile hallucinations in dementia with Lewy bodies. Psychogeriatrics. 2019;19:435-439.
Dieb W, Ouachikh O, Durif F, Hafidi A. Lesion of the dopaminergic nigrostriatal pathway induces trigeminal dynamic mechanical allodynia. Brain Behav. 2014;4:368-380.
Yang S, Boudier-Revéret M, Choo YJ, Chang MC. Association between chronic pain and alterations in the mesolimbic dopaminergic system. Brain Sci. 2020;10:701.
Suga T, Takenoshita M, Toyofuku A. Medical comorbidities of patients with burning mouth syndrome. Oral Dis. 2020;26:238-239.
Blanchet P, Rascol O. Survey on a subtype of chronic oral pain called burning mouth syndrome in Parkinson's disease. J Oral Facial Pain Headache. 2016;30:1-11.
Burkhart NW. Burning mouth syndrome. RDH. 2013;33:74-105.
Mendak M, Konopka T, Koszewicz M, Koziorowska-Gawron E, Budrewicz S. Nerve conduction in sensory and motor fibers of peripheral nerves in burning mouth syndrome. Adv Clin Exp Med. 2011;20:753-760.
Mendak M, Konopka T, Koszewicz M, Koziorowska-Gawron E, Ejma M, Budrewicz S. Similarities between burning mouth syndrome and Parkinson's disease. Adv Clin Exp Med. 2010;19:731-738.
Clifford T, Finnerty J. The dental awareness and needs of a Parkinson's disease population. Gerodontology. 1995;12:99-103.
Basker RM, Sturdee DW, Davenport JC. Patients with burning mouths. A clinical investigation of causative factors, including the climacteric and diabetes. Br Dent J. 1978;145:9-16.
Chaudhuri KR, Rizos A, Trenkwalder C, et al. King's Parkinson's disease pain scale, the first scale for pain in PD: an international validation. Mov Disord. 2015;30:1623-1631.
Silverdale MA, Kobylecki C, Kass-Iliyya L, et al. A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease. Parkinsonism Relat Disord. 2018;56:27-32.
Cenci MA. Presynaptic mechanisms of L-dopa-induced dyskinesia: the findings, the debate, and the therapeutic implications. Front Neurol. 2014;5:242.
Netto FO, Diniz IM, Grossmann SM, de Abreu MH, do Carmo MA, Aguiar MC. Risk factors in burning mouth syndrome: a case-control study based on patient records. Clin Oral Investig. 2011;15:571-575.
Suzuki N, Mashu S, Toyoda M, Nishibori M. Oral burning sensation: prevalence and gender differences in a Japanese population. Pain Pract. 2010;10:306-311.
Brailo V, Vuéiaeeviae-Boras V, Alajbeg IZ, Alajbeg I, Lukenda J, Aeurkoviae M. Oral burning symptoms and burning mouth syndrome-significance of different variables in 150 patients. Med Oral Patol Oral Cir Bucal. 2006;11:E252-E255.
Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med. 1999;28:350-354.
Lipton JA, Ship JA, Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc. 1993;124:115-121.
Riley JL III, Gilbert GH, Heft MW. Orofacial pain symptom prevalence: selective sex differences in the elderly? Pain. 1998;76(1-2):97-104.
Salat D, Tolosa E. Levodopa in the treatment of Parkinson's disease: current status and new developments. J Parkinsons Dis. 2013;3:255-269.
Li C, Liu S, Lu X, Tao F. Role of descending dopaminergic pathways in pain modulation. Curr Neuropharmacol. 2019;17:1176-1182.
Jääskeläinen SK. Pathophysiology of primary burning mouth syndrome. Clin Neurophysiol. 2012;123:71-77.
Grémeau-Richard C, Dubray C, Aublet-Cuvelier B, Ughetto S, Woda A. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial. Pain. 2010;149:27-32.
Winkelmann J, Schadrack J, Wetter TC, Zieglgänsberger W, Trenkwalder C. Opioid and dopamine antagonist drug challenges in untreated restless legs syndrome patients. Sleep Med. 2001;2:57-61.
Paulus W, Trenkwalder C. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol. 2006;5:878-886.
Prakash S, Ahuja S, Rathod C. Dopa responsive burning mouth syndrome: restless mouth syndrome or oral variant of restless legs syndrome? J Neurol Sci. 2012;320:156-160.
Turrini A, Raggi A, Calandra-Buonaura G, Martinelli P, Ferri R, Provini F. Not only limbs in atypical restless legs syndrome. Sleep Med Rev. 2018;38:50-55.